Company news
Apollomics Inc. news in 2025
Apollomics Inc.'s news releases, calls and decks from 2025, newest first.
Apollomics Reports First Half 2025 Financial Results
December 22, 2025
Apollomics Announces Settlement of Cayman Litigation
November 19, 2025
Apollomics Announces Changes to its Board of Directors and Composition of Committees
November 17, 2025
Apollomics Announces Continued Listing on The Nasdaq Stock Market Following Hearing Cancellation
October 15, 2025
Apollomics, Inc. Company Operational Continuity Update
October 13, 2025
Apollomics Announces Receipt of Nasdaq Delisting Notification, and Will Appeal to Retain
September 23, 2025
Apollomics Reports Full Year 2024 Financial Results and Highlights Clinical Updates and Business Progress
April 3, 2025
Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib
March 31, 2025